Therapeutic yoga has emerged as a significant lifestyle adjunct for managing type 2 diabetes mellitus (T2DM), with recent meta-analytical data indicating substantial improvements in glycemic control, including reductions in HbA1c and fasting plasma glucose. Despite these observed benefits, current clinical practices typically rely on standardized yoga protocols applied uniformly across diverse patient groups. This one-size-fits-all approach often leads to highly variable clinical outcomes, where some individuals experience significant improvements while others show minimal response. Researchers are now exploring whether the Ayurvedic concept of Prakriti—an individual’s innate constitutional makeup—could serve as a viable tool for stratifying patients and personalizing these therapeutic yoga interventions to address the persistent heterogeneity in treatment response.
A recent narrative review has synthesized current evidence to develop a hypothesis-generating framework for Prakriti-guided yoga, while simultaneously highlighting the substantial gaps in the existing research landscape. The review authors, Garima Gupta and Shweta Parwe, noted that while yoga combines various physical, breathing, and meditative practices that may influence physiological and psychological health, the underlying reasons for the varied responses to a uniform protocol remain unexplained. The proposed framework aims to integrate Ayurveda’s personalized approach to therapy, known as Yuktivyapashraya, with modern endocrinological management of T2DM, suggesting that by assessing a patient’s dominant Doshas—Vata, Pitta, and Kapha—clinicians might eventually tailor yoga prescriptions to better suit individual metabolic phenotypes.
The current body of research linking Prakriti to T2DM is limited to a small number of observational studies, none of which have prospectively evaluated a yoga intervention specifically tailored by Prakriti. These foundational studies have attempted to map Prakriti to various biological and metabolic correlates, including lipid fractions, inflammatory cytokines such as IL-6 and TNF-α, and HOMA-IR. While preliminary associations have been reported, these findings do not validate Prakriti as a clinical phenotype in a modern biomedical sense, nor do they establish that Prakriti can causally modify an individual’s response to a specific yoga regimen. Consequently, the review authors emphasize that these preliminary associations should not be interpreted as evidence of a validated link between constitutional types and diabetes outcomes.
Central to the proposed framework is a four-step implementation process involving constitutional assessment, phenotype mapping, the application of a prescribed yoga matrix, and ongoing monitoring. For the initial assessment, the authors suggest utilizing established tools like the CCRAS-PAQ to determine a patient’s dominant Dosha, alongside evaluations of Vikriti, or current functional imbalances, and Agni, or digestive capacity. The framework tentatively maps specific yoga modalities—such as grounding postures for Vata-dominant patients, cooling practices for Pitta-dominant types, and stimulating sequences for Kapha-dominant individuals—to address hypothesized phenotypic characteristics like neuropathy risk, systemic inflammation, or insulin resistance. However, these mappings are strictly exploratory and have not undergone empirical testing for clinical safety or efficacy.
Rigorous safety considerations remain a critical component of any yoga intervention in patients with T2DM, particularly those with existing diabetic complications. The review underscores that balance-dependent postures in patients with peripheral neuropathy and inverted postures in those with proliferative diabetic retinopathy carry significant risks of falls or ocular injury, respectively. Furthermore, clinicians must account for the potential for hypoglycemia, especially in patients treated with insulin or sulfonylureas, by timing sessions to avoid peak drug activity and monitoring blood glucose levels before and after practice. These safety parameters are considered essential for the responsible integration of any therapeutic yoga program, regardless of the level of personalization applied.
The authors stress that the proposed framework is explicitly hypothesis-generating and does not constitute a standard of care ready for routine clinical implementation. The current evidence base is heavily comprised of small, heterogeneous, and largely short-term studies, often centered within Indian populations, which makes the results susceptible to confounding factors such as diet, physical activity, and socioeconomic status. Moreover, the lack of prospective randomized trials that have specifically stratified yoga interventions by Prakriti means that any assumption of improved glycemic outcomes remains unproven. The researchers call for future trials to include well-characterized T2DM cohorts to determine if Prakriti-stratified protocols actually outperform standardized care.
Looking ahead, future research must move beyond retrospective assessments and observational data to definitively establish the utility of this approach. Prospective trials with pre-specified treatment-by-Prakriti interaction analyses are necessary to quantify whether constitutional differences truly account for the documented heterogeneity in yoga response. Standardizing video-based modules for Asana, Pranayama, and Dhyana practices, along with integrating metabolomic and genomic profiling, will be essential steps in identifying yoga-responsive endotypes. Such work would also require assessing the feasibility and cost-effectiveness of this personalized model within diverse healthcare settings, including integrative diabetes clinics and community-based digital health platforms.
Ultimately, while the integration of Prakriti into yoga research presents a promising conceptual avenue for personalized medicine, it must be carefully distinguished from validated clinical protocols. Prakriti classification should serve only as a potential variable for future research and not as a replacement for standard diabetes diagnosis or evidence-based treatments. The authors maintain that until adequately powered, prospectively registered trials confirm its clinical benefit and safety, the proposed framework remains a foundation for exploration rather than an established therapeutic tool. Rigorous clinical validation is the prerequisite for any future consideration of its application in the management of type 2 diabetes.
The authors conducted a focused narrative literature search across PubMed, Scopus, the AYUSH Research Portal, and the Dhara database, covering publications indexed from January 1, 2010, through May 31, 2026. The search strategy paired three comprehensive concept blocks combining terms for Prakriti and Dosha classifications with yoga modalities and type 2 diabetes outcomes. From an initial yield of approximately 845 deduplicated records, comprising roughly 320 citations from PubMed, 410 from Scopus, 75 from the AYUSH Research Portal, and 40 from Dhara, two independent reviewers screened titles and abstracts. A subset of approximately 55 full-text publications was evaluated, resulting in 28 referenced studies. The authors clarified that while this narrative mini review omitted a formal protocol and PRISMA flow diagram, documented search procedures ensured methodological transparency.
Quantitative insights from the referenced 2026 Bayesian three-level meta-analysis contextualize the broader therapeutic effects of yoga across 28 randomized controlled trials involving 2,241 adults with type 2 diabetes. That meta-analysis identified a pooled HbA1c reduction of 0.64 percent and a fasting plasma glucose reduction of 1.36 millimoles per liter, with more pronounced glycemic improvements occurring among individuals presenting with poorer baseline control, though overall certainty remained low. Potential physiological pathways highlighted in the synthesis include enhanced skeletal muscle glucose uptake, favorable modulation of the hypothalamic-pituitary-adrenal axis leading to reduced cortisol secretion, improved sympathovagal balance via vagal nerve stimulation, and reductions in circulating pro-inflammatory markers such as interleukin-6 and tumor necrosis factor-alpha. Yet because subgroup variables failed to resolve the notable heterogeneity in clinical response, unmeasured constitutional characteristics remain a plausible investigative target.
A closer examination of the three primary studies evaluating Prakriti in diabetes-related populations reveals substantial methodological constraints. In a cross-sectional study of 187 Indian adults with cardiovascular disease rather than a pure diabetes cohort, Mahalle and colleagues noted that Vata-Kapha Prakriti correlated with higher diabetes prevalence, dyslipidemia, elevated C-reactive protein, and increased insulin resistance. Separately, a study by Tiwari and coworkers involving 60 adults with diabetes demonstrated differential glycemic and lipid responses across constitutional types, but evaluated an aerobic walking intervention rather than therapeutic yoga. Additionally, Sivapuram and colleagues examined an observational subset of 35 participants within a yoga trial in Chandigarh and Panchkula, observing that individuals with type 2 diabetes and prediabetes were more frequently classified as Pitta and Vata-Pitta Prakriti. Beyond these studies, biological plausibility draws on genomic research linking Prakriti to single-nucleotide polymorphisms in the EGLN1 gene and the AYUR-genomics framework, which treat constitutional typing as a potential phenotypic marker without establishing clinical causality.
The conceptual architecture of the review is grounded in traditional Ayurvedic theory, where the Sanskrit term Prakriti combines pra, meaning forth, and kri, meaning to make, designating an innate constitution established at conception and considered permanent across the lifespan. Classical texts describe 20 subtypes of Prameha, an umbrella term for urinary and metabolic conditions that includes Madhumeha, associating Kapha predominance with obesity-like phenotypes, Vata with lean habitus, and Pitta with intermediate metabolic features. Alongside physical constitution, classical literature incorporates Manasika Prakriti, or mental constitution, delineated by the qualities of Sattva, Rajas, and Tamas. The authors hypothesize that tailoring mind-body modalities to mental predispositions could complement physical stratification, suggesting restorative practices like Yoganidra for Sattva, structured pacing for Rajas, and dynamic postures to overcome inertia in Tamas, although this theoretical personalization remains entirely untested.
To transition from theory to clinical inquiry, the framework outlines detailed practice parameters and prospective trial specifications. General practice guidelines suggest sessions lasting 30 to 60 minutes conducted five to six days weekly on an empty stomach or two hours following meals, integrated with dietary regulation and lifestyle habits. While baseline constitutional Prakriti is considered stable and is never reclassified, functional imbalances in Vikriti and digestive capacity, termed Agni, are scheduled for clinical reassessment every 12 weeks to guide ongoing adjustments. For prospective validation, the authors propose a randomized trial design that would use the standardized CCRAS-PAQ to stratify adults with type 2 diabetes into Kapha, Pitta, and Vata cohorts before randomizing participants within each stratum to Prakriti-tailored protocols, standardized diabetes yoga, or usual care. Evaluating 12-week changes in HbA1c alongside fasting glucose and lipids would determine whether constitutional personalization provides measurable clinical utility over uniform yoga programs.
Subject of Research: Evaluation of Prakriti-guided personalized yoga as an intervention for type 2 diabetes mellitus.
Article Title: Therapeutic yoga in type 2 diabetes mellitus: toward a Prakriti-guided personalized approach
Article References: Gupta, G., & Parwe, S. (2026). Therapeutic yoga in type 2 diabetes mellitus: toward a Prakriti-guided personalized approach. Frontiers in Endocrinology, 17, Article 1972889. https://doi.org/10.3389/fendo.2026.1972889
Image Credits: AI Generated
DOI: 10.3389/fendo.2026.1972889
Keywords: Type 2 Diabetes, Therapeutic Yoga, Prakriti, Ayurvedic Medicine, Personalized Medicine, Glycemic Control, Metabolic Phenotype, Lifestyle Intervention, Clinical Research, HbA1c, Insulin Sensitivity, Mind-Body Therapy, Dosha, Observational Study, Prospective Validation, Yoga Protocols, Diabetes Management
News Source: Ophelia Keating. (November 18, 2026). Proposed Personalized Yoga Framework for Type 2 Diabetes Awaits Clinical Validation. Scienmag.



